Fingerprint Dive into the research topics of 'Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma
Hiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, Junji Furuse, Hiroyuki Furukawa, Tatsuhiro Shibata
Research output: Contribution to journal › Article
18
Citations
(Scopus)